Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors

NCT00998036 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

DRUG: Temsirolimus
DRUG: Cisplatin
DRUG: Erlotinib

Sponsor

Columbia University

Collaborators

[object Object]
[object Object]